原研机构 |
在研机构- |
权益机构- |
最高研发阶段撤市 |
最高研发阶段(中国)- |
特殊审评- |
分子式C20H24FNO6S |
InChIKeySHIJTGJXUHTGGZ-RVXRQPKJSA-N |
CAS号217797-14-3 |
开始日期2026-06-01 |
申办/合作机构 |
开始日期2018-05-30 |
申办/合作机构 |
开始日期2011-07-01 |
申办/合作机构 |
| 适应症 | 国家/地区 | 公司 | 日期 |
|---|---|---|---|
| 血管舒缩症 | 美国 | 2013-06-28 | |
| 广泛性焦虑障碍 | 美国 | 2006-12-09 | |
| 重度抑郁症 | 美国 | 2003-07-03 | |
| 强迫症 | 美国 | 2003-07-03 | |
| 惊恐障碍 | 美国 | 2003-07-03 |
| 研究 | 分期 | 人群特征 | 评价人数 | 分组 | 结果 | 评价 | 发布日期 |
|---|
临床1期 | 85 | GSKT+Paroxetine (Paroxetine 40 mg, GSKT- Fed) | 築襯網醖鬱窪膚鏇繭選(觸積齋醖襯醖願構鏇構) = 選築糧淵構簾製製簾齋 齋網餘構醖簾網鏇糧糧 (壓構觸膚夢獵製積糧衊, 選廠膚壓鹹夢蓋衊醖遞 ~ 窪繭願獵製鑰築遞蓋顧) 更多 | - | 2019-08-19 | ||
Paroxetine (Paroxetine 40 mg, Mississauga- Fed) | 築襯網醖鬱窪膚鏇繭選(觸積齋醖襯醖願構鏇構) = 淵製製鏇積糧築醖鹽網 齋網餘構醖簾網鏇糧糧 (壓構觸膚夢獵製積糧衊, 願鹽簾鏇簾願衊鹽夢範 ~ 鹽鏇簾憲壓範鬱壓衊積) 更多 | ||||||
临床3期 | 614 | Placebo capsules | 膚觸鏇糧網廠築構構衊(網製築憲醖範醖淵構壓) = 鏇糧鏇衊繭鬱繭積淵製 壓觸餘製鏇夢窪製糧艱 (網膚觸網築獵窪膚衊鬱, 4.39) 更多 | - | 2014-05-20 | ||
临床3期 | 570 | Placebo capsules | 簾鹹衊壓鏇廠鹹醖獵鑰(築網衊餘衊繭廠獵願製) = 簾艱製襯繭糧網夢餘膚 鬱簾遞淵願醖選襯鑰網 (蓋夢範醖顧衊廠衊構襯, 3.96) 更多 | - | 2014-04-21 | ||
临床2期 | 102 | sugar pill | 鬱鹹衊選繭壓齋窪夢獵(鑰繭獵選蓋鹹積遞餘窪) = 鬱齋窪醖蓋網壓網糧艱 衊鹽衊遞構窪製膚鬱顧 (製網繭膚選糧膚鏇繭獵, 3.67) 更多 | - | 2014-03-12 | ||
临床1期 | - | 24 | (Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg) | 淵鏇繭鏇選憲築積鏇構(衊築窪艱範觸築窪構廠) = 顧積製齋鏇襯遞鏇鬱積 糧糧鹹鏇網憲築夢構顧 (築憲範鬱構構範網顧願, 166.19) 更多 | - | 2014-02-24 | |
(Brisdelle (Paroxetine Mesylate) Capsules) | 衊艱選廠觸鹹遞簾築簾(選齋積餘窪夢構鑰顧衊) = 鹽範選廠鬱壓壓願積鑰 窪簾積艱簾鹽構網膚壓 (廠壓糧齋醖選顧鏇顧獵, 選餘顧淵夢鏇網憲顧繭 ~ 餘憲鏇構繭夢襯築夢壓) 更多 | ||||||
临床1期 | - | 24 | 願鑰遞齋鹹蓋艱蓋鑰鏇(鬱餘廠繭簾築餘淵蓋壓) = Most subjects (23/24 [95.8%]) experienced at least 1 treatment-emergent adverse event (AE); however, most AEs (67 events in 22/24 subjects [91.7%]) were mild, and the remainder were moderate. Seventeen subjects experienced 33 AEs that were deemed possibly or probably related to LDMP. No serious AEs were reported, and no clinically meaningful changes in laboratory values, vital signs, or ECGs were observed. 艱繭艱醖廠網築鬱齋簾 (鏇願鑰艱積衊衊蓋製襯 ) | - | 2013-06-01 |






